These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 15722168

  • 21. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP.
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [Abstract] [Full Text] [Related]

  • 22. Properties of cell penetrating peptides (CPPs).
    Kerkis A, Hayashi MA, Yamane T, Kerkis I.
    IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
    [Abstract] [Full Text] [Related]

  • 23. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence.
    Ziegler A, Nervi P, Dürrenberger M, Seelig J.
    Biochemistry; 2005 Jan 11; 44(1):138-48. PubMed ID: 15628854
    [Abstract] [Full Text] [Related]

  • 24. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A, Eudes F, Shim YS.
    IUBMB Life; 2010 Mar 11; 62(3):183-93. PubMed ID: 20101631
    [Abstract] [Full Text] [Related]

  • 25. Tat peptide mediated cellular uptake of SiO2 submicron particles.
    Mao Z, Wan L, Hu L, Ma L, Gao C.
    Colloids Surf B Biointerfaces; 2010 Feb 01; 75(2):432-40. PubMed ID: 19846283
    [Abstract] [Full Text] [Related]

  • 26. Oligoarginine vectors for intracellular delivery: design and cellular-uptake mechanisms.
    Futaki S.
    Biopolymers; 2006 Feb 01; 84(3):241-9. PubMed ID: 16333858
    [Abstract] [Full Text] [Related]

  • 27. Cell-penetrating HIV1 TAT peptides float on model lipid bilayers.
    Ciobanasu C, Harms E, Tünnemann G, Cardoso MC, Kubitscheck U.
    Biochemistry; 2009 Jun 09; 48(22):4728-37. PubMed ID: 19400584
    [Abstract] [Full Text] [Related]

  • 28. Recent advances in cell-penetrating, non-peptide molecular carriers.
    Chung SK, Maiti KK, Lee WS.
    Int J Pharm; 2008 Apr 16; 354(1-2):16-22. PubMed ID: 17890027
    [Abstract] [Full Text] [Related]

  • 29. Cell-penetrating peptides and proteins: new inhibitors of allergic airways disease.
    Kinyanjui MW, Fixman ED.
    Can J Physiol Pharmacol; 2008 Apr 16; 86(1-2):1-7. PubMed ID: 18418441
    [Abstract] [Full Text] [Related]

  • 30. Cell-penetrating peptides for drug delivery across membrane barriers.
    Foged C, Nielsen HM.
    Expert Opin Drug Deliv; 2008 Jan 16; 5(1):105-17. PubMed ID: 18095931
    [Abstract] [Full Text] [Related]

  • 31. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo.
    Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Hickey R, Giordano FJ, Sessa WC.
    Nat Med; 2003 Mar 16; 9(3):357-62. PubMed ID: 12598894
    [Abstract] [Full Text] [Related]

  • 32. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
    Manceur A, Wu A, Audet J.
    Anal Biochem; 2007 May 01; 364(1):51-9. PubMed ID: 17379177
    [Abstract] [Full Text] [Related]

  • 33. Cell-penetrating peptides in drug development: enabling intracellular targets.
    Chen L, Harrison SD.
    Biochem Soc Trans; 2007 Aug 01; 35(Pt 4):821-5. PubMed ID: 17635156
    [Abstract] [Full Text] [Related]

  • 34. Arginine-rich cell-penetrating peptides.
    Schmidt N, Mishra A, Lai GH, Wong GC.
    FEBS Lett; 2010 May 03; 584(9):1806-13. PubMed ID: 19925791
    [Abstract] [Full Text] [Related]

  • 35. Cell-penetrating peptides are excluded from the mitochondrial matrix.
    Ross MF, Murphy MP.
    Biochem Soc Trans; 2004 Dec 03; 32(Pt 6):1072-4. PubMed ID: 15506968
    [Abstract] [Full Text] [Related]

  • 36. Recent advances in the use of cell-penetrating peptides for medical and biological applications.
    Fonseca SB, Pereira MP, Kelley SO.
    Adv Drug Deliv Rev; 2009 Sep 30; 61(11):953-64. PubMed ID: 19538995
    [Abstract] [Full Text] [Related]

  • 37. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P, Mäger I, Langel Ü.
    Trends Pharmacol Sci; 2010 Nov 30; 31(11):528-35. PubMed ID: 20828841
    [Abstract] [Full Text] [Related]

  • 38. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization.
    Fotin-Mleczek M, Welte S, Mader O, Duchardt F, Fischer R, Hufnagel H, Scheurich P, Brock R.
    J Cell Sci; 2005 Aug 01; 118(Pt 15):3339-51. PubMed ID: 16079278
    [Abstract] [Full Text] [Related]

  • 39. The many futures for cell-penetrating peptides: how soon is now?
    Howl J, Nicholl ID, Jones S.
    Biochem Soc Trans; 2007 Aug 01; 35(Pt 4):767-9. PubMed ID: 17635144
    [Abstract] [Full Text] [Related]

  • 40. Isolation of novel cell-penetrating peptides from a random peptide library using in vitro virus and their modifications.
    Kamide K, Nakakubo H, Uno S, Fukamizu A.
    Int J Mol Med; 2010 Jan 01; 25(1):41-51. PubMed ID: 19956900
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.